“…Because of these apparent advantages, use of MoM implants increased, and by 2006, they accounted for more than one-third of the US market [9,36]. Although initial reports were satisfactory [5,14,22,28,29], subsequent research demonstrated unacceptable early failure rates of monoblock MoM THAs, resulting in a substantial revision burden [2-4, 6, 7, 10, 12, 13, 15, 18, 19, 21, 24, 25, 27, 30, 32, 33, 36]. These revisions can be complicated by extensive soft tissue and bony defects, persistence of adverse local tissue reaction as well as problems associated with the general need to reduce the head size at the time of revision, perhaps increasing the likelihood of dislocation [1,3,7,10,13,18,19,23,25,31,33].…”